CPRIT presents a $300,000 check to UNT Health Science Middle for cancer research The Cancer Prevention and Study Institute of Texas recently presented a $300,000 check to the University of North Texas Health Science Center priligy 60 mg . The examine was recognized by the UNT Health Science Middle Provost Thomas Yorio, Ph.D., and Richard Kurz, Ph.D., dean of the institution of Public Health. ‘The UNT Health Science Center is very happy to be acknowledged by the Cancer Prevention and Study Institute of Texas for its continuing cancer study,’ Yorio stated. ‘CPRIT’s support of community-based cancer prevention programs in South Dallas will help improve early detection efforts to reduce cancers mortality in this area.


‘The recent FDA approval expanding the indication of our CRT-D devices – coupled with this strong financial data – showcases our commitment to treating heart failure and enhancing patient outcomes at every stage of treatment with this innovative portfolio of CRT-D therapies,’ stated David Steinhaus, M.D., Vice President and General Manager, Heart Failure, and Medical Director for the Cardiac Rhythm Disease Management business, Medtronic. ‘With the rising price of healthcare considerably impacting our global overall economy, it is important to supply high-value critically, safe, effective therapies like CRT-D, offering significant improvements at price thresholds deemed suitable to healthcare decision makers, as this analysis demonstrated.’..